首頁 > 市場調查報告書 > 製藥

藥物開發人工智能人工智能藥物研發

市場調查報告書

商品編碼

1529872

藥物發現中人工智慧的市場規模、佔有率和趨勢分析報告：按治療領域、按應用、按地區和細分市場預測，2024-2030

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Therapeutic Space (Oncology, Neurodegenerative Diseases), By Application, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年07月26日 | 出版商:

Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

藥物發現領域人工智慧市場的成長與趨勢：

預計到 2030 年，人工智慧在藥物發現領域的全球市場規模將達到 91 億美元，預計 2024 年至 2030 年複合年成長率將達到 29.7%。

預計2023年至2030年複合年成長率為29.6%。這場大流行導致人工智慧在製藥業的廣泛採用。人工智慧及其相關平台旨在增強醫學影像和診斷、慢性病管理和藥物設計。與掃描相同資料的人工智慧系統相比，它需要更多的人力時間，從而降低了整體成本並使其成為更可行的方法。

藥物最佳化和再利用應用領域在 2022 年佔據了最大的收益佔有率。人工智慧平台可以幫助識別藥物標靶蛋白，以確定潛在的藥物不利事件和副作用。藥物分子可以重複使用，以提高療效並最大限度地減少副作用。使用人工智慧平台可以更快地修改和研究公司的藥物組合，以加速開發新藥。

2022年，腫瘤學領域佔據最大的收益佔有率。大多數製藥公司正在與人工智慧新興企業合作最佳化癌症研究，但這仍然是一個未知領域，還有很多東西要發現。即使對於訓練有素的放射科醫生來說，人工智慧系統也能比常規掃描更早識別出癌症。其結果是壽命更長，還可以識別用於癌症研究和藥物開發的標記物。患者會接受適合其基因組成的治療。

2022年的市場由北美主導。目前，許多高科技公司正在投入資金和精力，在製藥公司中利用人工智慧。 IBM、微軟和其他科技巨頭等公司正在與研究機構建立合作關係，以加速多種適應症的藥物開發和臨床試驗。新興國家也在尋找經濟有效的方法來部署人工智慧技術來進行藥物開發和疾病理解。

藥物發現市場中的人工智慧報告亮點

藥物最佳化和再利用的應用領域佔據市場主導地位，2022年收益佔有率超過53.9%。
按治療領域分類，腫瘤學佔最大收益佔有率，2022 年將超過 23.4%。預計感染疾病產業在預測期內將出現最快的成長速度。
預計 2023 年至 2030 年，亞太地區將以最快的複合年成長率擴張。同時，該地區的新興國家擴大採用人工智慧作為了解疾病和支持藥物發現的手段。
北美地區引領市場，2022 年收益佔有率超過 58.0%。美國是人工智慧技術的先驅，為該地區的市場成長做出了重大貢獻。

全球藥物發現人工智慧 (AI) 市場：區域趨勢分析
2021 年和 2030 年全球人工智慧 (AI) 在藥物發現市場佔有率（按地區）
北美洲
- 北美人工智慧
- 美國
- 加拿大
- 墨西哥
歐洲
- 歐洲人工智慧
- 英國
- 德國
- 法國
- 西班牙
- 義大利
- 丹麥
亞太地區
- 亞太人工智慧
- 中國
- 印度
- 日本
- 澳洲
- 韓國
拉丁美洲
- 拉丁美洲的人工智慧
- 巴西
- 阿根廷
中東/非洲
- 中東/非洲人工智慧
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 科威特

第7章競爭分析

主要市場參與企業的最新趨勢和影響分析
公司/競爭對手分類（主要創新者、市場領導、新興企業）
競爭儀表板與公司市場分析
- 協同效應分析：重大交易與策略聯盟
- 主要新興企業/技術顛覆者/創新者名單

第8章競爭格局

IBM
- 公司簡介
- 財務表現
- 供品
- 策略舉措
Exscientia
- 公司簡介
- 財務表現
- 供品
- 策略舉措
GNS Healthcare（In January 2023, the company Rebranded as Aitia）
- 公司簡介
- 財務表現
- 供品
- 策略舉措
Google（DeepMind）
- 公司簡介
- 財務表現
- 供品
- 策略舉措
BenevolentAI
- 公司簡介
- 財務表現
- 供品
- 策略舉措
BioSymetrics, Inc
- 公司簡介
- 財務表現
- 供品
- 策略舉措
Atomwise Inc.
- 公司簡介
- 財務表現
- 供品
- 策略舉措
Berg Health（In January 2023, BPGbio Inc. acquired Berg Health）
- 公司簡介
- 財務表現
- 供品
- 策略舉措
insitro
- 公司簡介
- 財務表現
- 供品
- 策略舉措
CYCLICA（In May 2023, CYCLICA acquired by Recursion）
- 公司簡介
- 財務表現
- 供品
- 策略舉措

簡介目錄圖表

Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Growth & Trends:

The global artificial intelligence in drug discovery market size was estimated at USD 9.1 billion in 2030, and is expected to expand at a CAGR of 29.7% from 2024 to 2030. It is expected to expand at a CAGR of 29.6% from 2023 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.

The drug optimization and repurposing application segment held the largest revenue share in 2022. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2022. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2022. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights:

The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 53.9% in 2022
By therapeutic area, the oncology segment held the largest revenue share of over 23.4% in 2022. The infectious diseases segment is expected to register the fastest growth rate during the forecast period
Asia Pacific is expected to expand at the fastest CAGR from 2023 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery
North America led the market and accounted for a revenue share of over 58.0% in 2022. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology

Chapter 1 Methodology and Scope

1.1 Research Methodology
- 1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources

Chapter 2 Executive Summary

2.1 Market Summary

Chapter 3 Global Artificial Intelligence (AI) in Drug Discovery Market Variables, Trends & Scope

3.1 Market Segmentation
3.2 Artificial Intelligence (AI) in Drug Discovery Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
- 3.2.4 Global Artificial Intelligence (AI) in Drug Discovery Market: Pestle Analysis
- 3.2.5 Global Artificial Intelligence (AI) in Drug Discovery Market: Porter's Analysis

Chapter 4 Global Artificial Intelligence (AI) in Drug Discovery Market: Application Estimates & Trend Analysis

4.1 Artificial Intelligence (AI) in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
- 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.3 Preclinical Testing
- 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Other Applications
- 4.4.1 Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Global Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

5.1 Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
- 5.2.1 Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.3 Neurodegenerative Diseases
- 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Cardiovascular Disease
- 5.4.1 Cardiovascular Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5 Metabolic Diseases
- 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6 Infectious Disease
- 5.6.1 Infectious Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7 Others
- 5.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Global Artificial Intelligence (AI) in Drug Discovery Market: Regional Estimates & Trend Analysis

6.1 Global Artificial Intelligence (AI) in Drug Discovery Market Movement Ananlysis, By region
6.2 Global Artificial Intelligence (AI) in Drug Discovery Market Share, By region, 2021 & 2030
6.3 North America
- 6.3.1 North America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.2 U.S.
  - 6.3.2.1 U.S. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.3 Canada
  - 6.3.3.1 Canada Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.3.4 Mexico
  - 6.3.4.1 Mexico Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Europe
- 6.4.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.2 U.K.
  - 6.4.2.1 U.K. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.3 Germany
  - 6.4.3.1 Germany Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.4 France
  - 6.4.4.1 France Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.5 Spain
  - 6.4.5.1 Spain Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.6 Italy
  - 6.4.6.1 Italy Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.4.7 Denmark
  - 6.4.7.1 Denmark Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Asia Pacific
- 6.5.1 Asia Pacific Artificial intelligence (AI) in drug discovery market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.2 China
  - 6.5.2.1 China Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.3 India
  - 6.5.3.1 India Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.4 Japan
  - 6.5.4.1 Japan Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.5 Australia
  - 6.5.5.1 Australia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.5.6 South Korea
  - 6.5.6.1 South Korea Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Latin America
- 6.6.1 Latin America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.6.2 Brazil
  - 6.6.2.1 Brazil Artificial Intelligence (AI) in Drug Discovery Market
- 6.6.3 Argentina
  - 6.6.3.1 Argentina Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7 MEA
- 6.7.1 MEA Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.2 South Africa
  - 6.7.2.1 South Africa Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.3 Saudi Arabia
  - 6.7.3.1 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.4 UAE
  - 6.7.4.1 UAE Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.7.5 Kuwait
  - 6.7.5.1 Kuwait Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3. Competitive Dashboard & Company Market Position Analysis
- 7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
- 7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators

Chapter 8 Competitive Landscape

8.1 IBM
- 8.1.1 Company Overview
- 8.1.2 Finanacial Performance
- 8.1.3 Offerings
- 8.1.4 Strategic Initiatives
8.2 Exscientia
- 8.2.1 Company Overview
- 8.2.2 Finanacial Performance
- 8.2.3 Offerings
- 8.2.4 Strategic Initiatives
8.3 GNS Healthcare (In January 2023, the company Rebranded as Aitia)
- 8.3.1 Company Overview
- 8.3.2 Finanacial Performance
- 8.3.3 Offerings
- 8.3.4 Strategic Initiatives
8.4 Google (DeepMind)
- 8.4.1 Company Overview
- 8.4.2 Finanacial Performance
- 8.4.3 Offerings
- 8.4.4 Strategic Initiatives
8.5 BenevolentAI
- 8.5.1 Company Overview
- 8.5.2 Finanacial Performance
- 8.5.3 Offerings
- 8.5.4 Strategic Initiatives
8.6 BioSymetrics, Inc
- 8.6.1 Company Overview
- 8.6.2 Finanacial Performance
- 8.6.3 Offerings
- 8.6.4 Strategic Initiatives
8.7 Atomwise Inc.
- 8.7.1 Company Overview
- 8.7.2 Finanacial Performance
- 8.7.3 Offerings
- 8.7.4 Strategic Initiatives
8.8 Berg Health (In January 2023, BPGbio Inc. acquired Berg Health)
- 8.8.1 Company Overview
- 8.8.2 Finanacial Performance
- 8.8.3 Offerings
- 8.9.4 Strategic Initiatives
8.10 insitro
- 8.10.1 Company Overview
- 8.10.2 Finanacial Performance
- 8.10.3 Offerings
- 8.10.4 Strategic Initiatives
8.11 CYCLICA (In May 2023, CYCLICA acquired by Recursion)
- 8.11.1 Company Overview
- 8.11.2 Finanacial Performance
- 8.11.3 Offerings
- 8.11.4 Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1 Partial list of secondary sources
Table 2 North America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 3 North America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 U.S. Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 6 Canada Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 7 Canada Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 8 Mexico Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 9 Mexico Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 10 Europe Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 11 Europe Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 12 UK Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 13 UK Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 14 Germany Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 15 Germany Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 16 France Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 17 France Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 18 Spain Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 19 Spain Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 20 Italy Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 21 Italy Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 Denmark Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 23 Denmark Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 24 Sweden Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 25 Sweden Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Norway Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 27 Norway Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 China Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 31 China Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 32 India Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 33 India Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 Japan Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 35 Japan Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 36 Australia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 37 Australia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 South Korea Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 39 South Korea Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 40 Latin America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 41 Latin America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Brazil Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 43 Brazil Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 44 Argentina Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 45 Argentina Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Middle East & Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 47 Middle East & Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 48 South Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 49 South Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Saudi Arabia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 51 Saudi Arabia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 52 UAE Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 53 UAE Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Kuwait Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 55 Kuwait Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Global Artificial Intelligence in drug discovery market snapshot, 2021 (USD Million)
Fig. 9 Global Artificial Intelligence in drug discovery market segmentation
Fig. 10 Global Artificial Intelligence in drug discovery market dynamics
Fig. 11 Global Artificial Intelligence in drug discovery market driver impact
Fig. 12 Global Artificial Intelligence in drug discovery market restraints impact
Fig. 13 Global Artificial Intelligence in drug discovery market - PESTLE analysis
Fig. 14 Global Artificial Intelligence in drug discovery market - Porter's Analysis
Fig. 15 Global Artificial Intelligence in drug discovery market - Application outlook and key takeaways
Fig. 16 Global Artificial Intelligence in drug discovery market - Application movement analysis
Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Preclinical testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Global Artificial Intelligence in drug discovery market - Therapeutic area outlook and key takeaways
Fig. 21 Global Artificial Intelligence in drug discovery market - Therapeutic area movement analysis
Fig. 22 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cardiovascular Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Metabolic Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Infectious Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Global Artificial Intelligence in drug discovery market - Regional outlook and key takeaways
Fig. 29 Global Artificial Intelligence in drug discovery market - Regional movement analysis
Fig. 30 North America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Canada Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Mexico Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Europe Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.K. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Germany Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 France Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Spain Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Italy Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Denmark Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Sweden Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 China Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 India Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Latin America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Argentina Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Middle East & Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53. South Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 UAE Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Kuwait Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Recent Developments & Impact Analysis, By Key Market Participants
Fig. 58 Company market position analysis, 2023
Fig. 59 Strategic alliance and deals analysis